PEPG
PepGen is a biotechnology company focused on developing disease-modifying therapies for genetic neuromuscular and neurological diseases. The company emphasizes pioneering science and a pipeline aimed at safely targeting root causes of serious conditions. Its work centers on genetic medicine and delivery technologies to expand treatment options, with operations and research highlighted on its global website. PepGen positions itself as advancing a new generation of genetic therapies through its science and clinical pipeline.
No recent news for this company.
No recent deals for this company.